Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 228.30M | $ 307.70M | $ 280.70M | $ 177.50M | $ 339.60M |
Total Assets | $ 1.75B | $ 1.82B | $ 1.77B | $ 1.64B | $ 1.21B |
Total Debt | $ ― | $ ― | $ ― | $ 278.80M | $ 273.20M |
Net Debt | $ ― | $ ― | $ ― | $ 101.30M | $ -66.40M |
Total Liabilities | $ 1.35B | $ 1.40B | $ 1.34B | $ 1.27B | $ 958.80M |
Stockholders Equity | $ 402.30M | $ 425.80M | $ 428.20M | $ 361.80M | $ 253.20M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |